However, IBD patients often display increased intestinal permeability and impaired epithelial barrier function [67,68,69,70], leading to elevated levels of pro-inflammatory cytokines such TNF-α, IFN-γ, interleukin (IL)-1, IL-6, and IL-12 [71]. The gene discussed is IL1B; the disease is irritable bowel syndrome.